PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

patent!, could mean sp increase ?, page-19

  1. sweetsynergy
    222 Posts.
    clock Created with Sketch.
    03/02/10
    12:15
    Post #: 6281444
    Prostate cancer is the 2nd most diagnosed cancer for men, around 1 in 6 men will develop the disease. This could move again nicely if the US patent which is pending is granted for this prostate tumour inhibiting drug.

    They also have other projects on the go.
    Advanced trials for Multiple Sclerosis.
    Pre-clinical trails for asthma etc.
    ANP Price at posting: 5.7¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Almonty locks in govt agreement for tungsten oxide plant in South Korea
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
BHP BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
NEWS Bitcoin investors need to know the risks
right-arrow Created with Sketch.
NIM Nimy to raise $1.21M to explore 'newsy' WA targets
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
8.1¢ 8.1¢ 7.9¢ $33.53K 416.4K

Buyers (Bids)

No. Vol. Price($)
2 92000 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 65186 3
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.